![](https://investorshub.advfn.com/uicon/792403.png?cb=1632160976)
Monday, January 09, 2023 2:35:03 PM
- It would seem all profit would flow up to the parent entity (unnamed European pharma company), and Enzolytics says the deal gives Enzolytics 50% of "profit derived from sales in the Licensed Territory" without specifying ITV-1 profits only. They left it ambiguous.
- How could Enzolytics have 50% ownership across the board but not 50% revenue sharing across the board?
- If the revenue sharing part of the deal was indeed for ITV-1 revenue only, there would be no revenue since ITV-1 isn't for sale yet.
If instead ENZC would share all profits from this entity, here are some possibilities:
- ENZC should already have been showing revenue and its accounting is bad.
- That parent entity is making zero revenue and thus has none to share.
- That part of the agreement hasn't taken effect yet. ( "Enzolytics will receive $1 Million USD and 50% ownership in the Licensing Entity valued at $8 Million.")
Will be curious to see how it transpires.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM